AstraZeneca seeks to steal respiratory crown from longtime UK rival GSK - S&P Global

AstraZeneca seeks to steal respiratory crown from longtime UK rival GSK  S&P Global

The U.K. has a long history of leading research into respiratory diseases, stemming from the Industrial Revolution and early studies into tuberculosis.



Comments

Popular posts from this blog

“Stem cells: A possible treatment for severe respiratory failure, a COVID-19 complication - Mirage News” plus 1 more

“Screening for hearing loss in primary care - Contemporary Pediatrics” plus 1 more

“Evidence of cross-species filovirus transmission from bats to humans - EurekAlert” plus 2 more